Hiv Infection

Bringing a new perspective to infectious disease

Studying infectious diseases has long been primarily the domain of biologists. However, as part of the Ragon Institute, MIT engineers and physical scientists are joining immunologists and physicians in the ...

HIV & AIDS created Feb 08, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

HIV exploits a human cytokine in semen to promote its own transmission

A new report suggests that the concentration of one human cytokine, interleukin 7 (IL-7), in the semen of HIV-1-infected men may be a key determinant of the efficiency of HIV-1 transmission to an uninfected female partner. ...

HIV & AIDS created Feb 07, 2013 | popularity 5 / 5 (1) | comments 0

Social media may prove useful in prevention of HIV, STDs, study shows

(Medical Xpress)— Facebook and other social networking technologies could serve as effective tools for preventing HIV infection among at-risk groups, new UCLA research suggests.

HIV & AIDS created Feb 06, 2013 | popularity not rated yet | comments 0

Extra-couple HIV transmission a major driver of Africa's HIV epidemic

New research suggests that heterosexual couples in long-term relationships who have sexual encounters outside their established partnership (extra-couple relationships) are one of the main drivers of the HIV epidemic in sub-Saharan ...

HIV & AIDS created Feb 04, 2013 | popularity not rated yet | comments 0

Study finds incentive price for reducing HIV risk in Mexico

Studies have found that conditional cash transfer programs, in which governments pay citizens if they consistently practice societally beneficial behaviors, have improved pediatric health care and education ...

HIV & AIDS created Feb 04, 2013 | popularity not rated yet | comments 0

Early therapy for HIV vital

New insight into the optimal timing of therapy for HIV infection could give patients a better chance of responding to potential cure strategies of the future.

HIV & AIDS created Feb 01, 2013 | popularity not rated yet | comments 0

Improved prevention measures fail to reduce HIV levels in men who have sex with men in England and Wales

The rate of new HIV infections among men who have sex with men in England and Wales has remained unchanged over the past decade despite an almost four-fold increase in HIV testing, rising treatment coverage, and a 20 percent ...

HIV & AIDS created Jan 31, 2013 | popularity not rated yet | comments 0

A 'neurosteroid' found to prevent brain injury caused by HIV/AIDS

A team of scientists from Canada, Thailand and Morocco have found that DHEA-S may prevent neurocognitive impairment that affects a significant percentage of AIDS patients. In a report appearing in the February 2013 issue ...

HIV & AIDS created Jan 31, 2013 | popularity 4 / 5 (1) | comments 0

Patient satisfaction leads to better HIV care

In a study of patients at two HIV clinics in the Houston area, researchers at Baylor College of Medicine and the Michael E. DeBakey Veterans Affairs Medical Center found that those who were satisfied with the care they received ...

HIV & AIDS created Jan 30, 2013 | popularity not rated yet | comments 0

Tenofovir Gel wins out in drug absorption study, but HIV prevention trials say differently

A novel head-to-head study looking at differences in how the antiretroviral (ARV) drug tenofovir gets absorbed in the body as either an oral tablet or a vaginal gel found tenofovir gel can achieve substantially higher concentrations ...

HIV & AIDS created Jan 30, 2013 | popularity not rated yet | comments 0

Study reveals two-fold higher incidence of non-melanoma skin cancers for HIV patients

HIV-positive patients have a higher incidence of non-melanoma skin cancers, according to a Kaiser Permanente study that appears in the current online issue of the Journal of the National Cancer Institute. Specifically, basal ...

Cancer created Jan 29, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Half of at-risk older adults aren't getting routine HIV screening

One in four people with HIV/AIDS is over 50, yet older adults are more often diagnosed at a late stage than younger people. Despite this, nearly half of older adults visiting a public health clinic where ...

HIV & AIDS created Jan 29, 2013 | popularity not rated yet | comments 0

Predicting survival among those aging with HIV infection

(Medical Xpress)—A new collaborative study led by Yale, the VA Healthcare System, and the North American Cohort Collaboration supports the accuracy of an index used for predicting mortality as patients ...

HIV & AIDS created Jan 29, 2013 | popularity not rated yet | comments 0

Longtime smokers lose a decade of life

(HealthDay)—Adding to the arsenal of evidence that smoking is bad for you, a large new study indicates that lifetime smokers cut 10 years off their life expectancy—a decade they can gain back if they ...

Health created Jan 24, 2013 | popularity 5 / 5 (2) | comments 0

Study finds 'Achilles heel' of key HIV replication protein

Researchers at the University of Pittsburgh School of Medicine may have found an "Achilles heel" in a key HIV protein. In findings published online today in Chemistry and Biology, they showed that targeting this vulnerable spot c ...

HIV & AIDS created Jan 24, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast


Human immunodeficiency virus (HIV) is a lentivirus (a member of the retrovirus family) that causes acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells. The four major routes of transmission are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her baby at birth (perinatal transmission). Screening of blood products for HIV has largely eliminated transmission through blood transfusions or infected blood products in the developed world.

HIV infection in humans is considered pandemic by the World Health Organization (WHO). Nevertheless, complacency about HIV may play a key role in HIV risk. From its discovery in 1981 to 2006, AIDS killed more than 25 million people. HIV infects about 0.6% of the world's population. In 2009, AIDS claimed an estimated 1.8 million lives, down from a global peak of 2.1 million in 2004. Approximately 260,000 children died of AIDS in 2009. A disproportionate number of AIDS deaths occur in Sub-Saharan Africa, retarding economic growth and exacerbating the burden of poverty. An estimated 22.5 million people (68% of the global total) live with HIV in sub-Saharan Africa, which is also home to 90% of the world's 16.6 million children orphaned by HIV. Treatment with antiretroviral drugs reduces both the mortality and the morbidity of HIV infection. Although antiretroviral medication is still not universally available, expansion of antiretroviral therapy programs since 2004 has helped to turn the tide of AIDS deaths and new infections in many parts of the world. Intensified awareness and preventive measures, as well as the natural course of the epidemic, have also played a role. Nevertheless, an estimated 2.6 million people were newly infected in 2009.

HIV infects vital cells in the human immune system such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through three main mechanisms: First, direct viral killing of infected cells; second, increased rates of apoptosis in infected cells; and third, killing of infected CD4+ T cells by CD8 cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections.

Most untreated people infected with HIV-1 eventually develop AIDS. These individuals mostly die from opportunistic infections or malignancies associated with the progressive failure of the immune system. HIV progresses to AIDS at a variable rate affected by viral, host, and environmental factors; most will progress to AIDS within 10 years of HIV infection: some will have progressed much sooner, and some will take much longer. Treatment with anti-retrovirals increases the life expectancy of people infected with HIV. Even after HIV has progressed to diagnosable AIDS, the average survival time with antiretroviral therapy was estimated to be more than 5 years as of 2005[update]. Without antiretroviral therapy, someone who has AIDS typically dies within a year.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

Vitamin D could provide new and effective treatments for asthma

(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...

Research uncovers a potential role of two proteins in diabetes

(Medical Xpress)—Flinders University researchers are breaking new ground in a decade-long journey to pinpoint the function of two closely related proteins.

Lymphatic fluid takes detour

When tumours metastasise, they can block lymphatic vessels, as researchers from ETH Zurich have discovered using a new method. The lymphatic fluid subsequently has to find a new path through the tissue. Such ...

Immune protein could stop diabetes in its tracks

Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.

Measles surges in UK years after vaccine scare

More than a decade ago, British parents refused to give measles shots to at least a million children because of a vaccine scare that raised the specter of autism. Now, health officials are scrambling to catch ...

Treatment of sleep apnea improves glucose levels in prediabetes

Optimal treatment of sleep apnea in patients with prediabetes improves blood sugar (glucose) levels and thus can reduce cardiometabolic risk, according to a study to be presented at the ATS 2013 International Conference in ...

Whole-cell vaccine was more effective than acellular vaccine during CA pertussis outbreak

Whole-cell pertussis vaccines were more effective at protecting against pertussis than acellular pertussis vaccines during a large recent outbreak, according to a new Kaiser Permanente study published in Pediatrics.

Blame your parents for bunion woes

A novel study reports that white men and women of European descent inherit common foot disorders, such as bunions (hallux valgus) and lesser toe deformities, including hammer or claw toe. Findings from the Framingham Foot ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...